STOCKHOLDERS' EQUITY (Tables)

6 Months Ended

Jun. 30, 2026

STOCKHOLDERS' EQUITY

Schedule of common stock issued roll forward

The following table represents a share reconciliation of the Company’s common stock issued for the periods presented:

​	Three Months Ended June 30,		Six Months Ended June 30,
	2026	2025	2026	2025
Common stock:
Balance, beginning of period	211,059,707	197,536,271	207,785,762	195,028,207
Shares issued for stock options exercised	816	15,870	8,710	72,282
Agent growth incentive stock-based compensation	1,002,375	859,028	1,634,649	1,305,685
Agent equity stock-based compensation	4,477,051	3,038,414	7,087,098	5,043,409
Other stock-based compensation	29,120	-	52,850	-
Other share activity	(2,715,349)	-	(2,715,349)	-
Balance, end of period	213,853,720	201,449,583	213,853,720	201,449,583

Changes in the Company's stock compensation liability

The following table illustrates changes in the Company’s stock-based compensation liability for the periods presented:

	Amount
Balance, December 31, 2024	$ 5,045
Stock grant liability increase year to date	2,736
Stock grants reclassified from liability to equity year to date	(1,999)
Balance, December 31, 2025	$ 5,782
Stock grant liability increase year to date	2,353
Stock grants reclassified from liability to equity year to date	(1,315)
Balance, June 30, 2026	$ 6,820